CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ1CUB5

Market Closed - Deutsche Boerse AG 20:34:16 24/05/2024 BST
51.95 EUR +1.82% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+5.25%
1 month+6.45%
Date Price Change
24/05/24 51.95 +1.82%
23/05/24 51.02 -1.56%
22/05/24 51.83 -1.56%
21/05/24 52.65 -1.05%
20/05/24 53.21 +0.30%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 08:34 pm

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ1CUB
ISINDE000DJ1CUB5
Date issued 27/04/2023
Strike 60
Maturity 20/12/2024 (209 Days)
Parity 1 : 1
Emission price 45.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 53.87
Lowest since issue 33.15
Spread 0.1
Spread %0.19%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus